Growth & profitability
- Revenue has grown 273.4% per year over the past 4 years.
Financial health
- Operating income covered interest expense -23.8× in the latest year.
ONCO Financials Onconetix, Inc.
5 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
RevenueNet income
GrossOperatingNet
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key annual figures
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $815371 | -$14M | 77.6% | -2190.0% | — | — | $5M |
| 2024 | $3M | -$59M | 41.8% | -2238.0% | -$11M | — | $646500 |
| 2023 | $58465 | -$37M | -1927.9% | -61634.5% | -$14M | — | $5M |
| 2022 | — | -$13M | — | — | -$9M | — | $26M |
| 2021 | — | -$3M | — | — | -$2M | — | $2M |
RevenueNet income
GrossOperatingNet
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key quarterly figures
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $21457 | -$4M | -7.7% | -47657.2% | — | — | $4M |
| Dec '25 | $303596 | $6M | 81.6% | -422.1% | — | — | $5M |
| Sep '25 | $303651 | -$9M | 88.6% | -681.5% | — | — | $836556 |
| Jun '25 | $106494 | -$2M | 66.2% | -1817.4% | — | — | $283515 |
| Mar '25 | $101630 | -$9M | 45.1% | -12369.2% | — | — | $2M |
| Dec '24 | $711976 | -$29M | 92.7% | -4093.7% | -$921521 | — | $646500 |
| Sep '24 | $406859 | -$4M | 25.9% | -650.3% | -$1M | — | $341495 |
| Jun '24 | $704848 | -$14M | 14.3% | -1931.6% | -$3M | — | $930541 |
| Mar '24 | $700433 | -$11M | 27.0% | -1582.2% | -$5M | — | $4M |
| Dec '23 | — | -$22M | — | — | -$4M | — | $5M |
| Sep '23 | — | -$5M | — | — | -$3M | — | $8M |
| Jun '23 | — | -$7M | — | — | -$2M | — | $9M |
| Mar '23 | — | -$3M | — | — | -$4M | — | $21M |
| Dec '22 | — | -$3M | — | — | -$3M | — | $26M |
| Sep '22 | — | -$4M | — | — | -$2M | — | $29M |
| Jun '22 | — | -$4M | — | — | -$3M | — | $22M |
| Mar '22 | — | -$2M | — | — | -$891288 | — | $19M |
| Dec '21 | — | -$1M | — | — | — | — | $2M |
| Sep '21 | — | -$1M | — | — | — | — | $3M |
| Jun '21 | — | -$792274 | — | — | — | — | $4M |
Valuation over time
How the market has priced ONCO against its own fundamentals since 2023-12 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
- The price-to-sales ratio has fallen from 38.3× (Jan '24) to 13.7× (Jun '26).
P/S
Frequently asked questions
Is ONCO growing its revenue and profit?
Over the past 4 years, Onconetix, Inc.'s revenue has grown 273.4% per year. These are computed facts, not advice.
How much debt does ONCO have?
As of FY2025, Onconetix, Inc. reported — of total debt against $5M of cash; operating income covered interest expense -23.8×.
What is ONCO's profit margin?
In FY2025, gross margin was 77.6%, operating margin -2190.0%, and net margin -1721.0%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.